Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

1.71
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
1.35
Today|||52-Week Range
4.69
-31.60%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close1.71
Today’s open1.69
Day’s range1.68 - 1.73
Volume118,763
Average volume (3 months)470,185
Market cap$35.1M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+9.64%
Earnings growth (this year)+42.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+105.25%
P/E ratioNM
Price/Sales1.60
Price/Book4.95

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...0.000.00%
PRPHProPhase Labs Inc0.000.00%
FCSCFibrocell Science In...0.000.00%
PULMPulmatrix Inc0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateMarch 21, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$19.9M
Annual profit (last year)-$19.1M
Net profit margin-95.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
CFO, Secretary &
Principal Accounting Officer
Andrew R. Boll
Corporate headquarters
San Diego, California

Forecasts